Description
MOTS-c 40 mg Mitochondrial-Derived Research Peptide
MOTS-c 40 mg is a mitochondrial-derived research peptide supplied as a lyophilized powder for advanced laboratory investigation. MOTS-c is a short 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA region and is studied as a signalling molecule involved in communication between mitochondria, the nucleus and wider cellular systems.
Each vial contains 40 mg of MOTS-c research peptide. This format is relevant to controlled studies involving mitochondrial signalling, cellular stress adaptation, AMPK-related pathways, glucose metabolism, skeletal-muscle homeostasis, exercise biology and healthy-aging research.
Unlike conventional peptides encoded within nuclear DNA, MOTS-c originates from a small open reading frame inside mitochondrial DNA. This distinctive genetic origin has made it an important subject in the expanding field of mitochondrial-derived peptides, which investigates how mitochondria communicate information about energy status, nutrient availability and cellular stress.
What Is MOTS-c?
The name MOTS-c is derived from “mitochondrial open reading frame of the 12S rRNA type-c.” It refers to a naturally encoded peptide consisting of 16 amino acids. MOTS-c was originally identified during research into small mitochondrial open reading frames and their potential role in metabolic regulation.
Mitochondria are best known for their contribution to cellular energy production, but they also function as dynamic signalling centres. They respond to changes in nutrients, redox balance, physical activity and cellular stress. Mitochondrial-derived peptides such as MOTS-c are investigated as messenger molecules that may help translate these internal mitochondrial conditions into wider cellular responses .
MOTS-c research includes metabolism, skeletal muscle, exercise adaptation, inflammatory signalling, oxidative stress and age-related changes in cellular function. Most interventional findings remain preclinical, while human studies have primarily examined naturally occurring MOTS-c levels, genetic variants and physiological responses to exercise.
Mitochondrial Origin and Retrograde Signalling
Human mitochondrial DNA is a compact circular genome traditionally associated with proteins involved in oxidative phosphorylation, ribosomal RNAs and transfer RNAs. The discovery of biologically active peptides encoded within regions of mitochondrial RNA expanded the understanding of mitochondrial genetics.
MOTS-c is encoded within the mitochondrial 12S rRNA region. Rather than acting as a structural mitochondrial protein, it is studied as a signalling peptide capable of participating in mitochondrial retrograde signalling. This term describes communication from the mitochondria back to the nucleus and other cellular systems.
Retrograde signalling allows cells to adjust gene expression and metabolic activity in response to changes in mitochondrial function. Under experimental metabolic stress, MOTS-c has been observed moving into the nucleus, where it is associated with stress-responsive transcriptional pathways. This behaviour supports research into how mitochondrial information may influence nuclear adaptation, cellular defence and metabolic flexibility .
AMPK and Cellular Energy-Sensing Research
A central area of MOTS-c research involves AMP-activated protein kinase, commonly abbreviated as AMPK. AMPK acts as a cellular energy sensor and responds when energy demand increases relative to available supply.
Experimental work links MOTS-c with changes in the folate cycle and de novo purine biosynthesis. These changes may contribute to the accumulation of AICAR, an AMP-related metabolite associated with AMPK activation. Researchers study this pathway to understand how MOTS-c may influence cellular adaptation during nutrient or energy stress.
AMPK signalling is connected with multiple metabolic processes, including glucose uptake, fatty-acid oxidation, mitochondrial adaptation and the regulation of energy-intensive biosynthesis. MOTS-c is therefore relevant to studies examining how mitochondrial-derived signals interact with broader energy-sensing networks.
The relationship between MOTS-c and AMPK should be understood as an experimental mechanism rather than a guaranteed product effect. Results depend on the biological model, material quality, study conditions and analytical methods used.
Glucose Metabolism and Metabolic Flexibility
MOTS-c was first described in research connecting mitochondrial genetics with systemic metabolic regulation. Early experimental studies examined glucose utilization, insulin-related signalling and metabolic responses in cellular and animal models .
Skeletal muscle is a major site of glucose disposal and has become an important focus of MOTS-c research. Laboratory investigations may evaluate glucose uptake, transporter-associated signalling, substrate utilization and the ability of cells or tissues to adapt between carbohydrate and fat metabolism.
This ability to adjust fuel selection is often described as metabolic flexibility. Researchers may examine how mitochondrial signals contribute to this adaptation under different nutritional, exercise or stress conditions. MOTS-c provides a research tool for studying these relationships at the level of cellular signalling and mitochondrial communication.
Human observational research has reported associations between circulating MOTS-c and metabolic phenotypes, but results vary according to age, sex, body composition, assay method and health status. Association does not demonstrate that experimentally increasing MOTS-c will reproduce the same outcome.
Exercise and Skeletal-Muscle Research
Exercise creates a rapid increase in cellular energy demand and is one of the strongest physiological challenges to metabolic homeostasis. MOTS-c has attracted attention as an exercise-responsive mitochondrial peptide because endogenous levels have been observed to change in skeletal muscle and circulation around physical activity.
Preclinical studies have also examined MOTS-c in relation to physical capacity, muscle metabolism and age-associated changes in performance. Research areas include glycolysis, amino-acid metabolism, mitochondrial stress responses and pathways involved in skeletal-muscle adaptation.
More recent mechanistic studies have investigated interactions between MOTS-c and proteins involved in muscle glucose metabolism and structural regulation. Genetic research has also examined naturally occurring mitochondrial variants that alter the MOTS-c sequence and may influence the relationship between physical activity, metabolic traits and muscle biology.
These findings make MOTS-c 40 mg relevant to controlled laboratory models of muscle energetics and exercise adaptation. They do not establish guaranteed improvements in strength, endurance, recovery or athletic performance.
Cellular Stress and Nuclear Adaptation
Cells constantly respond to changes in nutrient availability, oxidative balance, temperature, mechanical demand and other environmental pressures. Mitochondrial signals form part of this adaptive network because changes in energy production can influence the function of the entire cell.
Under experimental metabolic stress, MOTS-c has been reported to translocate toward the nucleus. Research has linked this behaviour with transcription factors involved in antioxidant responses, proteostasis and cellular defence. These observations support the view of MOTS-c as a mitochondrial-to-nuclear messenger rather than only a circulating metabolic marker.
Laboratory studies may examine gene-expression changes, stress-response proteins, redox markers and mitochondrial function after controlled exposure to MOTS-c. Appropriate controls are essential because many stress pathways overlap and can be affected by cell type, nutrient conditions and experimental duration.
Healthy-Aging Research
Mitochondrial function, metabolic flexibility, stress resistance and skeletal-muscle capacity often change with age. MOTS-c is studied within healthy-aging biology because it connects several of these areas through mitochondrial signalling, AMPK-related pathways, muscle metabolism and cellular stress responses.
Some experimental and observational studies have examined age-related differences in endogenous MOTS-c levels. Animal research has explored physical capacity and functional measures in older models, while human studies have investigated associations between circulating MOTS-c, age and metabolic characteristics.
The scientifically appropriate focus is healthy-aging and metabolic-resilience research, not guaranteed age reversal or lifespan extension. Human intervention evidence remains limited, and findings from animal models should not be converted directly into claims about human longevity.
MOTS-c Compared with SS-31
MOTS-c and SS-31 are both discussed in mitochondrial research, but they have different origins and primary areas of investigation. MOTS-c is a mitochondrially encoded peptide studied mainly in metabolic signalling, AMPK activity, stress adaptation and communication between mitochondria and the nucleus.
SS-31, also known as elamipretide, is a synthetic tetrapeptide primarily investigated for its interaction with cardiolipin and the structural environment of the inner mitochondrial membrane. MOTS-c therefore represents a signalling-focused research approach, while SS-31 is more closely associated with mitochondrial membrane organization.
This distinction is useful for researchers selecting compounds for different experimental questions. The two peptides should not be treated as interchangeable simply because both are associated with mitochondrial biology.
MOTS-c 40 mg Product Specifications
Compound name: MOTS-c
Full name: Mitochondrial open reading frame of the 12S rRNA type-c
Vial content: 40 mg
Sequence length: 16 amino acids
Genetic origin: Mitochondrial 12S rRNA region
Compound class: Mitochondrial-derived peptide
Physical form: Lyophilized powder
Research areas: AMPK signalling, glucose metabolism, cellular stress, skeletal muscle, exercise biology and healthy aging
Purity: Refer to the batch-specific Certificate of Analysis
Lyophilized MOTS-c 40 mg Format
MOTS-c 40 mg is supplied in lyophilized powder form to support controlled storage, handling and inventory management in a research environment. The dry material should remain sealed and clearly labelled with the compound name, stated vial content and batch information.
The 40 mg value identifies the total quantity stated for the complete vial. It does not establish an experimental concentration or protocol. The responsible researcher should determine all study conditions using validated methods and appropriate institutional documentation.
Visual appearance alone cannot verify peptide identity, content, purity, stability or suitability. Researchers should review the matching Certificate of Analysis and any available batch-specific records before beginning analytical work.
Research Applications
MOTS-c 40 mg may be relevant to qualified laboratory research involving mitochondrial-derived peptide signalling, cellular energy sensing, AMPK pathways, glucose utilization, metabolic flexibility, skeletal-muscle homeostasis, exercise responses, oxidative stress and mitochondrial-to-nuclear communication.
The peptide may also support comparative work examining endogenous and synthetic MOTS-c, mitochondrial genetic variants, age-related signalling or metabolic responses under different nutrient and stress conditions.
Study design should account for the biological model, experimental objective, peptide identity and analytical method. Concentrations, controls, preparation procedures and endpoints must be established by trained researchers rather than inferred from the total vial content.
Quality and Batch Traceability
Reliable peptide research requires accurate product identification and traceable batch information. Verify that the vial label and supporting records consistently identify MOTS-c, the 40 mg total content, the physical form and the corresponding batch or sample number.
A batch-specific analytical document should identify the tested material, method, test date and reported result. Purity or independent-testing claims should only be used when supported by documentation for the exact MOTS-c 40 mg batch supplied.
Material characteristics may vary between suppliers and production lots. Results from one batch cannot automatically be transferred to another. Researchers remain responsible for determining whether the supplied material meets the requirements of the planned analytical or biological work.
Store the unopened vial according to the conditions stated in the accompanying documentation. Protect the material from contamination, moisture, excessive heat and direct light, and maintain appropriate inventory, handling and disposal records.
Evidence and Interpretation
MOTS-c has a strong mechanistic research basis as a mitochondrial-derived signalling peptide, but the evidence varies between cellular, animal and observational human studies. Experimental findings involving AMPK, glucose metabolism, exercise adaptation or healthy aging should be interpreted according to the specific model and study design.
Claims of guaranteed weight reduction, improved insulin sensitivity, enhanced athletic performance, accelerated recovery or reversal of aging would exceed the available evidence. Accurate presentation should focus on compound identity, documented specifications and the biological pathways investigated in scientific research.
For laboratory and animal research only. Not intended for human use.